Del. Court Says Pharma Co. Must Delist 'Orange Book' Patent
Jazz Pharmaceuticals has two weeks to ask the U.S. Food and Drug Administration to pull a patent that purportedly covers a narcolepsy drug from the agency's so-called Orange Book after a...To view the full article, register now.
Already a subscriber? Click here to view full article